Clinical Trials
12 trialsNCT00490529 2020-01-13
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
Stanford University
Phase 2 Completed
NCT00880581 2017-03-14
A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas
Stanford University
Phase 2 Completed
NCT00824733 2016-01-14
Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Terminated
NCT00471159 2015-05-04
A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.
Pfizer
Phase 2 Withdrawn
NCT00085189 2014-05-22
Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma
University of Southern California
Phase 2 Completed
NCT00321815 2010-12-23
Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer
Pfizer
Phase 2 Completed
NCT00313768 2009-09-28
Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC
Pfizer
Phase 2 Terminated
NCT00321308 2009-09-28
Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer
Pfizer
Phase 2 Terminated
NCT00043368 2009-03-12
PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)
Pfizer
Phase 2 Completed
NCT00043394 2009-03-12
CPG 7909 Plus HerceptinĀ® In Patients With Metastatic Breast Cancer
Pfizer
Phase 2 Completed
NCT00070629 2009-02-10
CPG 7909 Injection in Non-Small Cell Lung Cancer
Pfizer
Phase 2 Completed
NCT00070642 2009-02-10
CPG 7909 Injection in Melanoma
Pfizer
Phase 2 Completed